
|Articles|November 14, 2012
Stereotactic body RT efficacious in localized PCa
Stereotactic body radiotherapy appears to be an effective treatment option for patients with organ-confined prostate cancer, according to two separate studies presented at the American Association for Radiation Oncology annual meeting in Boston.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kristen Scarpato, MD, on combination strategies in BCG-naïve NMIBC
2
FDA updates in urology: January 2026
3
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
4
FDA premarket approval sought for Signatera CDx test in MIBC
5






